This study looks at two different interventions used for the treatment of insomnia in survivors of breast, colon, lung, prostate and gynecologic cancer.

The purpose of this study is to evaluate two validated interventions for the treatment of insomnia in cancer survivors of breast, colon, lung and prostate cancer. Moreover, it will provide an opportunity to assess the efficacy of both of these interventions in a group setting in patients of varied ethnic backgrounds including African-Americans, Latinos and Caucasians. The results of this study will help clinicians provide future interventions specific to cancer type and ethnicity in order to better serve the needs of our cancer survivors and improve their quality of life.

Inclusion Criteria:

• signed informed consent
• age 18 and over
• diagnosis of breast, colon, lung, prostate or gynecologic cancer that is non metastatic
• receiving treatment at one of the outpatient offices of the MD Anderson Cancer Center at Cooper
• Self reported insomnia
• Not currently taking any medications to treat insomnia
• No medical or psychological condition that would prevent successful protocol completion in the opinion of investigator.